A poll released Tuesday shows a majority of people support the ACA's contraceptive mandate -- despite strong opposition from some religious groups.
Nebraska Gov. Dave Heineman (R) on Tuesday vetoed a bill that would have granted nurse practitioners more autonomy in their practices.
The immediate past governor of the Connecticut chapter of the American College of Physicians explains why granting nurse practitioners greater freedom in his state is a poor decision.
Hospital mergers are not always made in heaven and regulators don't always buy the "bigger is better" approach, Kaiser Health News reports.
A radiation oncologist takes issue with the "war" analogy used to describe cancer treatment.
A bill to rein in the medical marijuana industry in California moved forward yesterday, passing through a state assembly committee.
What are the psychological consequences of calling obesity a disease?
Talking about personalized technology in medicine, Kevin Campbell, MD, says that "no other discipline has seen science fiction become reality and produce human impact as readily as medicine and the treatment of human disease."
A political action committee for celebrity neurosurgeon Ben Carson, MD, has raised nearly $2.4 million in the first 3 months of the year for a prospective run for the presidency in 2016.
The FDA has proposed a way to expedite the approval of medical devices that address unmet medical needs for patients with serious conditions.
Despite near constant pushback from doctors on health IT, there's no turning back, writes one healthcare industry analyst.
Have you ever had a doctor break up with you? asks a patient with multiple myeloma.
The Obama administration official in charge of Medicare for the past 5 years has resigned, according to the Chicago Tribune.
Sales of the da Vinci surgical robot are slipping, related to a drop in gynecologic procedures, Reuters reported.
Amgen reported disappointing profits in first quarter of the year, at least partly stemming from lower demand for etanercept (Enbrel).
The oral MS drug dimethyl fumarate (Tecfidera) is definitely a blockbuster, with 1st-quarter sales on track to bring in $2 billion in 2014 for its manufacturer, Biogen Idec.
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.